Platelet-Rich Plasma for Elbow Pathologies: a Descriptive Review of Current Literature

Adam Kwapisz, Sharad Prabhakar, Riccardo Compagnoni, Aleksandra Sibilska, Pietro Randelli, Adam Kwapisz, Sharad Prabhakar, Riccardo Compagnoni, Aleksandra Sibilska, Pietro Randelli

Abstract

Purpose of review: Platelet-rich plasma is used in many orthopedic pathologies such as tendinopathies and ligament injuries. The clinical results reported in the scientific literature are, however, confusing. The aim of this manuscript is to provide a narrative literature review regarding the role of PRP in the most common elbow soft tissue pathologies.

Recent findings: The response to PRP seems to be favorable when compared to steroid injection for pain management and for patient-reported outcomes in lateral epicondylitis. PRP injection does not seem to have the potential complications associated with a steroid injection such as skin atrophy, discoloration, and secondary tendon tears. Only a few manuscripts comparing the results of PRP treatment with either extracorporeal shockwave (ESW), dry needling, or even surgical treatments in lateral epicondylitis exist. The use of PRP in other elbow pathologies such as golfer's elbow, ulnar collateral ligament injury, and distal biceps and triceps pathology is examined in few studies, with unclear recommendations. Regarding elbow pathologies, PRP injections in tennis elbow seems to be the best-studied intervention. A major limitation in these studies is the significant heterogeneity in the methods used for preparing PRP, for example employing leukocyte-rich, leukocyte-poor preparations, PRP with or without activation, which makes the results of the studies difficult to compare. Results of this review show that more studies on larger cohorts, with comparable formulations, and with longer follow-up are required to give optimal suggestions concerning the use of PRP in elbow pathologies.

Keywords: Elbow; Golfer’s elbow; Platelets-rich plasma; Tendinopathy; Tennis elbow.

Conflict of interest statement

Conflict of Interest

Dr. Randelli is a consultant for Arthrex, Depuy, Microport, and Medacta. He is president of Sigascot Italian Nat Soc Arthroscopy. All other authors declare no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

    1. Chen Xiao, Jones Ian A., Park Caron, Vangsness C. Thomas. The Efficacy of Platelet-Rich Plasma on Tendon and Ligament Healing: A Systematic Review and Meta-analysis With Bias Assessment. The American Journal of Sports Medicine. 2017;46(8):2020–2032. doi: 10.1177/0363546517743746.
    1. Andia I, Rubio-Azpeitia E, Maffulli N. Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes. Clin Orthop Relat Res. 2015;473(5):1624–1634. doi: 10.1007/s11999-015-4179-z.
    1. Galatz LM, Gerstenfeld L, Heber-Katz E, Rodeo SA. Tendon regeneration and scar formation: the concept of scarless healing. J Orthop Res. 2015;33(6):823–831. doi: 10.1002/jor.22853.
    1. Hudgens JL, Sugg KB, Grekin JA, Gumucio JP, Bedi A, Mendias CL. Platelet-rich plasma activates proinflammatory signaling pathways and induces oxidative stress in tendon fibroblasts. Am J Sports Med. 2016;44(8):1931–1940. doi: 10.1177/0363546516637176.
    1. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27(8):1033–1042. doi: 10.1002/jor.20853.
    1. De Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, van Osch GJ. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 2008;36(6):1171–1178. doi: 10.1177/0363546508314430..
    1. De Mos M, Koevoet W, van Schie HT, Kops N, Jahr H, Verhaar JA, van Osch GJ. In vitro model to study chondrogenic differentiation in tendinopathy. Am J Sports Med. 2009;37(6):1214–1222. doi: 10.1177/0363546508331137.
    1. Filardo G, Kon E. PRP: product rich in placebo? Knee Surg Sports Traumatol Arthrosc. 2016;24(12):3702–3703. doi: 10.1007/s00167-015-3778-2.
    1. Taylor DW, Petrera M, Hendry M, Theodoropoulos JS. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med. 2011;21(4):344–352. doi: 10.1097/JSM.0b013e31821d0f65.
    1. Nourissat G, Ornetti P, Berenbaum F, Sellam J, Richette P, Chevalier X. Does platelet-rich plasma deserve a role in the treatment of tendinopathy? Joint Bone Spine. 2015;82(4):230–234. doi: 10.1016/j.jbspin.2015.02.004.
    1. Mishra A, Randelli P, Barr C, Talamonti T, Ragone V, Cabitza P. Platelet-rich plasma and the upper extremity. Hand Clin. 2012;28(4):481–491. doi: 10.1016/j.hcl.2012.08.008.
    1. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial. Am J Sports Med. 2010;38(2):255–232. doi: 10.1177/0363546509355445.
    1. Kraushaar BS, Nirschl RP. Tendinosis of the elbow (tennis elbow). Clinical features and findings of histological, immunohistochemical, and electron microscopy studies. J Bone Joint Surg Am. 1999;81(2):259–278. doi: 10.2106/00004623-199902000-00014.
    1. Verhaar JA. Tennis elbow. Anatomical, epidemiological and therapeutic aspects. Int Orthop. 1994;18(5):263–267. doi: 10.1007/BF00180221.
    1. Chard MD, Hazleman BL. Tennis elbow--a reappraisal. Br J Rheumatol. 1989;28(3):186–190. doi: 10.1093/rheumatology/28.3.186.
    1. Arirachakaran A, Sukthuayat A, Sisayanarane T, Laoratanavoraphong S, Kanchanatawan W, Kongtharvonskul J. Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis. J OrthopTraumatol. 2016;17(2):101–112. doi: 10.1007/s10195-015-0376-5.
    1. Nirschl RP, Pettrone FA. Tennis elbow The surgical treatment of lateral epicondylitis. J Bone Joint Surg Am. 1979;61(6A):832–839. doi: 10.2106/00004623-197961060-00005.
    1. Arrigoni P, Cucchi D, D’Ambrosi R, Butt U, Safran MR, Denard P, Randelli P. Intra-articular findings in symptomatic minor instability of the lateral elbow (SMILE) Knee Surg Sports Traumatol Arthrosc. 2017;25(7):2255–2263. doi: 10.1007/s00167-017-4530-x.
    1. Lebiedziński Radosław, Synder Marek, Buchcic Piotr, Polguj Michał, Grzegorzewski Andrzej, Sibiński Marcin. A randomized study of autologous conditioned plasma and steroid injections in the treatment of lateral epicondylitis. International Orthopaedics. 2015;39(11):2199–2203. doi: 10.1007/s00264-015-2861-0.
    1. Krogh TP, Bartels EM, Ellingsen T, Stengaard-Pedersen K, Buchbinder R, Fredberg U, Bliddal H, Christensen R. Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials. Am J Sports Med. 2013;41(6):1435–1446. doi: 10.1177/0363546512458237.
    1. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011;39(6):1200–1208. doi: 10.1177/0363546510397173.
    1. Mi B, Liu G, Zhou W, Lv H, Liu Y, Wu Q, Liu J. Platelet rich plasma versus steroid on lateral epicondylitis: meta-analysis of randomized clinical trials. Phys Sportsmed. 2017;45(2):97–104. doi: 10.1080/00913847.2017.1297670..
    1. Gautam VK, Verma Saurabh, Batra Sahil, Bhatnagar Nidhi, Arora Sumit. Platelet-Rich Plasma versus Corticosteroid Injection for Recalcitrant Lateral Epicondylitis: Clinical and Ultrasonographic Evaluation. Journal of Orthopaedic Surgery. 2015;23(1):1–5. doi: 10.1177/230949901502300101.
    1. • Yadav R, Kothari SY, Borah D. Comparison of local injection of platelet rich plasma and corticosteroids in the treatment of lateral epicondylitis of humerus.J Clin Diagn Res 2015;9(7):RC05-7. At 3 months, significant improvement in pain and function scores in the PRP group (Steroid group had better initial pain relief which declined subsequently).
    1. P B, Dhillon M, Aggarwal S, Marwaha N, Prakash M. Leukocyte-poor platelet-rich plasma versus bupivacaine for recalcitrant lateral epicondylar tendinopathy. J Orthop Surg (Hong Kong) 2015;23(1):6–10. doi: 10.1177/230949901502300102.
    1. Khaliq A, Khan I, Inam M, Saeed M, Khan H, Iqbal MJ. Effectiveness of platelets rich plasma versus corticosteroids in lateral epicondylitis. J Pak Med Assoc. 2015;65(11 Suppl 3):S100–S104.
    1. Palacio EP, Schiavetti RR, Kanematsu M, Ikeda TM, Mizobuchi RR, Galbiatti JA. Effects of platelet-rich plasma on lateral epicondylitis of the elbow: prospective randomized controlled trial. Rev Bras Ortop. 2016;51(1):90–95. doi: 10.1016/j.rboe.2015.03.014.
    1. Mishra A, Harmon K, Woodall J, Jr, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13(7):1185–1195. doi: 10.2174/138920112800624283.
    1. Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA, Ramsey ML, Karli DC, Rettig AC. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42(2):463–471. doi: 10.1177/0363546513494359.
    1. Creaney L. Platelet-rich plasma and the biological complexity of tissue regeneration. Br J Sports Med. 2011;45(8):611. doi: 10.1136/bjsm.2010.082594.
    1. • Raeissadat SA, Rayegani SM, Hassanabadi H, Rahimi R, Sedighipour L, Rostami K. Is platelet-rich plasma superior to whole blood in the management of chronic tennis elbow: one year randomized clinical trial. BMC Sports Sci Med Rehabil 2014;6(1):12. doi: 10.1186/2052-1847-6-12. Although scores of both groups improved over 12 months, no significant difference between PRP vs ABI.
    1. Chou LC, Liou TH, Kuan YC, Huang YH, Chen HC. Autologous blood injection for treatment of lateral epicondylosis: a meta-analysis of randomized controlled trials. Phys Ther Sport. 2016;18:68–73. doi: 10.1016/j.ptsp.2015.06.002.
    1. Thanasas Christos, Papadimitriou George, Charalambidis Charalambos, Paraskevopoulos Ilias, Papanikolaou Athanasios. Platelet-Rich Plasma Versus Autologous Whole Blood for the Treatment of Chronic Lateral Elbow Epicondylitis. The American Journal of Sports Medicine. 2011;39(10):2130–2134. doi: 10.1177/0363546511417113.
    1. Ford RD, Schmitt WP, Lineberry K, Luce P. A retrospective comparison of the management of recalcitrant lateral elbow tendinosis: platelet-rich plasma injections versus surgery. Hand. 2015;10(2):285–291. doi: 10.1007/s11552-014-9717-8.
    1. Alessio-Mazzola M, Repetto I, Biti B, Trentini R, Formica M, Felli L. Autologous US-guided PRP injection versus US-guided focal extracorporeal shock wave therapy for chronic lateral epicondylitis: a minimum of 2-year follow-up retrospective comparative study. J OrthopSurg (Hong Kong) 2018;26(1):230949901774998. doi: 10.1177/2309499017749986.
    1. Lim W, Park SH, Kim B, Kang SW, Lee JW, Moon YL. Relationship of cytokine levels and clinical effect on platelet-rich plasma-treated lateral epicondylitis. J Orthop Res. 2018;36(3):913–920.
    1. Gaspar MP, Motto MA, Lewis S, Jacoby SM, Culp RW, Lee Osterman A, Kane PM. Platelet-rich plasma injection with percutaneous needling for recalcitrant lateral epicondylitis: comparison of tenotomy and fenestration techniques. Orthop J Sports Med. 2017;5(12):232596711774207. doi: 10.1177/2325967117742077.
    1. Karaduman Mert, Okkaoglu Mustafa Caner, Sesen Hakan, Taskesen Anil, Ozdemir Mahmut, Altay Murat. Platelet-rich plasma versus open surgical release in chronic tennis elbow: A retrospective comparative study. Journal of Orthopaedics. 2016;13(1):10–14. doi: 10.1016/j.jor.2015.12.005.
    1. Merolla G, Dellabiancia F, Ricci A, Mussoni MP, Nucci S, Zanoli G, Paladini P, Porcellini G. Arthroscopic debridement versus platelet-rich plasma injection: a prospective, randomized, comparative study of chronic lateral epicondylitis with a nearly 2-year follow-up. Arthroscopy. 2017;33(7):1320–1329. doi: 10.1016/j.arthro.2017.02.009.
    1. Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226–233. doi: 10.1177/0363546516643716.
    1. Shiri R, Viikari-Juntura E. Lateral and medial epicondylitis: role of occupational factors. Best Pract Res Clin Rheumatol. 2011;25(1):43–57. doi: 10.1016/j.berh.2011.01.013.
    1. Wolf JM, Mountcastle S, Burks R, Sturdivant RX, Owens BD. Epidemiology of lateral and medial epicondylitis in a military population. Mil Med. 2010;175(5):336–339. doi: 10.7205/MILMED-D-09-00086.
    1. Tyler TF, Nicholas SJ, Schmitt BM, Mullaney M, Hogan DE. Clinical outcomes of the addition of eccentrics for rehabilitation of previously failed treatments of golfers’ elbow. Int J Sports Phys Ther. 2014;9(3):365–370.
    1. Varshney A, Maheshwari R, Juyal A, Agrawal A, Hayer P. Autologous platelet-rich plasma versus corticosteroid in the management of elbow epicondylitis: a randomized study. Int J App Basic Med Res. 2017;7(2):125–128. doi: 10.4103/2229-516X.205808.
    1. Taylor SA, Hannafin JA. Evaluation and management of elbow tendinopathy. Sports Health. 2012;4(5):384–393. doi: 10.1177/1941738112454651.
    1. Donaldson O, Vannet N, Gosens T, Kulkarni R. Tendinopathies around the elbow part 2: medial elbow, distal biceps and triceps tendinopathies. Should Elb. 2014;6(1):47–56. doi: 10.1111/sae.12022.
    1. Dines JS, Williams PN, Attrache N, Conte S, Tomczyk T, Osbahr DC, Dines DM, Bradley J, Ahmad CS. Platelet-rich plasma can be used to successfully treat elbow ulnar collateral ligament insufficiency in high-level throwers. Am J Orthop. 2016;45(5):296–300.
    1. Rettig AC, Sherrill C, Snead DS, Mendler JC, Mieling P. Nonoperative treatment of ulnar collateral ligament injuries in throwing athletes. Am J Sports Med. 2001;29(1):15–17. doi: 10.1177/03635465010290010601.
    1. Podesta L, Crow SA, Volkmer D, Bert T, Yocum LA. Treatment of partial ulnar collateral ligament tears in the elbow with platelet-rich plasma. Am J Sports Med. 2013;41(7):1689–1694. doi: 10.1177/0363546513487979.
    1. Deal J. Banks, Smith Ed, Heard Wendell, O’Brien Michael J., Savoie Felix H. Platelet-Rich Plasma for Primary Treatment of Partial Ulnar Collateral Ligament Tears: MRI Correlation With Results. Orthopaedic Journal of Sports Medicine. 2017;5(11):232596711773823. doi: 10.1177/2325967117738238.
    1. Hurwit DJ, Garcia GH, Liu J, Altchek DW, Romeo A, Dines J. Management of ulnar collateral ligament injury in throwing athletes: a survey of the American Shoulder and Elbow Surgeons. J Shoulder Elb Surg. 2017;26(11):2023–2028. doi: 10.1016/j.jse.2017.08.005.
    1. Barker SL, Bell SN, Connell D, Coghlan JA. Ultrasound-guided platelet-rich plasma injection for distal biceps tendinopathy. Should Elb. 2015;7(2):110–114. doi: 10.1177/1758573214567558.
    1. Sanli I, Morgan B, van Tilborg F, Funk L, Gosens T. Single injection of platelet-rich plasma (PRP) for the treatment of refractory distal biceps tendonitis: long-term results of a prospective multicenter cohort study. Knee Surg Sports Traumatol Arthrosc. 2016;24(7):2308–2312. doi: 10.1007/s00167-014-3465-8.
    1. Cheatham SW, Kolber MJ, Salamh PA, Hanney WJ. Rehabilitation of a partially torn distal triceps tendon after platelet rich plasma injection: a case report. Int J Sports Phys Ther. 2013;8(3):290–299.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel